Binhuan Wang

New York University

Papers

1

Total Citations

38

H-Index

1

About

Dr. Binhuan Wang is a distinguished biostatistician whose research bridges advanced statistical methodology with pressing clinical challenges in oncology and surgical outcomes. Her work is centered on the rigorous evaluation of novel therapeutic technologies, particularly in head and neck cancers. A landmark contribution is her study on the adoption and safety of transoral robotic surgery (TORS) for oropharyngeal cancers, which provided critical real-world evidence on the procedure’s uptake and risk profile following FDA approval. This highly cited work (38 citations) has informed clinical guidelines and patient counseling. Beyond this, Dr. Wang’s expertise in analyzing large-scale healthcare databases and developing robust statistical models for survival analysis has enabled her to assess treatment efficacy, surgical safety, and disparities in cancer care. Her research consistently translates complex data into actionable insights, impacting both clinical practice and health policy. With a growing portfolio of influential publications, Dr. Wang is recognized for her methodological rigor and her commitment to improving patient outcomes through evidence-based surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers
38 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: New York University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago